Skip to main content
logo
BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.80
-1.30 (-4.05%)
At close: Aug 28, 2026

BIONET Therapeutics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
2,2653,9343,252--
Market Cap Growth
-36.19%20.99%---
Enterprise Value
1,2572,8012,381--
Last Close Price
32.3556.2046.45--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
11.5225.4739.99--
PB Ratio
1.903.242.51--
P/TBV Ratio
1.903.242.51--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
6.3918.1329.28--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.020.01---
Net Debt / Equity Ratio
-0.84-0.86-0.94-0.99-1.11
Net Debt / EBITDA Ratio
12.339.9512.6413.56-
Net Debt / FCF Ratio
11.107.577.1111.3415.53
Asset Turnover
0.150.120.090.02-
Inventory Turnover
2.653.125.31--
Quick Ratio
15.9918.9723.0243.609.95
Current Ratio
16.7519.7023.7443.719.98
Return on Equity (ROE)
-6.87%-7.76%-9.46%-12.95%-
Return on Assets (ROA)
-4.93%-5.53%-6.57%-8.26%-
Return on Capital Employed (ROCE)
-8.40%-9.50%-7.70%-7.40%-25.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-3.71%-2.48%-2.65%--
FCF Yield
-4.01%-3.52%-5.26%--
Buyback Yield / Dilution
-3.39%-21.88%-280.50%-1278.45%-